Study to assess whether Inhalational Bronchodilator given prior to bronchoscopy reduces discomfort due to breathlessness and cough
Phase 4
- Conditions
- Health Condition 1: null- Patients with any respiratory disease leading to FEV1/FVC less than 70%
- Registration Number
- CTRI/2013/04/003520
- Lead Sponsor
- Department of Medicine AIIMS
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 50
Inclusion Criteria
â?¦All patients undergoing fibreoptic bronchoscopy and having evidence of airway obstruction as assessed by spirometry i.e FEV1/FVC < 70 %
â?¦Patients who give consent for the study
Exclusion Criteria
Those who are not willing to participate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ï?½To determine whether use of inhaled bronchodilator prior to bronchoscopy provides a protective effect in patients with underlying airway obstruction. <br/ ><br> <br/ ><br>Timepoint: Pulmonary Function Test will be done within 2 hours post bronchoscopy. <br/ ><br> <br/ ><br>
- Secondary Outcome Measures
Name Time Method To evaluate whether this intervention ( MDI salbutamol ) has any beneficial effect on procedure related outcomes.Timepoint: questionnaires will be filled by patient regarding symptoms before and after Bronchoscopy.